A Historical overview of natural products in drug discovery

Metabolites

Volumn 2, Issue 2, 2012, Pages 303-336

  Dias, Daniel A ^a   Urban, Sylvia ^b   Roessner, Ute ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Algae; Bioactivity; Dereplication; Drug discovery; Fungi; Metabolomics; Natural products; Plants; Secondary metabolites; Sponges

Indexed keywords

ARTEMISININ; BAL 19403; BETA LACTAM; BEVIRIMAT; BRYOSTATIN 1; CALANOLIDE A; CETHROMYCIN; CYTARABINE; DEHYDRODIDEMNIN B; DIGITOXIN; DOXORUBICIN; ERIBULIN; ERYTHROMYCIN; HALICHONDRIN B; INGENOL MEBUTATE; NATURAL PRODUCT; OMEGA CONOTOXIN MVIIA; PACLITAXEL; PG 49088; PILOCARPINE; PIPERAQUINE; QUININE; RESTANZA; SORAFENIB; TRABECTEDIN; UNCLASSIFIED DRUG; VANCOMYCIN; VIDARABINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE LYMPHOBLASTIC LEUKEMIA; ALGA; ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; BIOSYNTHESIS; BREAST CANCER; BREAST CARCINOMA; CONGESTIVE HEART FAILURE; DATA BASE; DRUG DESIGN; FEVER; GLAUCOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HODGKIN DISEASE; HUMAN; IC 50; INDIGESTION; INFECTION; INFLAMMATORY DISEASE; INFRARED SPECTROSCOPY; KIDNEY CARCINOMA; LEUKEMIA; MALARIA; MASS SPECTROMETRY; METABOLOMICS; MOUTH DISEASE; NEOPLASM; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE; OSTEOSARCOMA; PAIN; PENICILLIUM CHRYSOGENUM; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; SJOEGREN SYNDROME; SKIN CANCER; SOFT TISSUE SARCOMA; SPONGE (PORIFERA); THROAT DISEASE; VIRUS INFECTION; XEROSTOMIA;

EID: 84878280763     PISSN: None     EISSN: 22181989     Source Type: Journal    
DOI: 10.3390/metabo2020303     Document Type: Review

References (160)

1. Mishra, B.B.; Tiwari, V.K. Natural products: An evolving role in future drug discovery. Eur. J. Med. Chem. 2011, 46, 4769-4807.
2. Rey-Ladino, J.; Ross, A.G.; Cripps, A.W.; McManus, D.P.; Quinn, R. Natural products and the search for novel vaccine adjuvants. Vaccine 2011, 29, 6464-6471.
3. Cragg, G.M.; Newman, D.J. Biodiversity: A continuing source of novel drug leads. Pure Appl. Chem. 2005, 77, 7-24.
4. Haefner, B. Drugs from the deep: Marine natural products as drug candidates. Drug Discov. Today 2003, 8, 536-544.
5. Butler, M.S. The role of natural product in chemistry in drug discovery. J. Nat. Prod. 2004, 67, 2141-2153.
6. Hicks, S. Desert Plants and People, 1st ed.; Naylor Co.: San Antonio, TX, USA, p. 75.
7. Kinghorn, A.D.; Pan, L.; Fletcher, J.N.; Chai, H. The relevance of higher plants in lead compound discovery programs. J. Nat. Prod. 2011, 74, 1539-1555.
8. Duke, J.A.; Duke, P.A.K.; du Cellier, J.L. Duke's Handbook of Medicinal Plants of the Bible; CRC Press Taylor and Francis Group: Boca Raton, FL, USA, 2008; p. 552.
9. Dillenius, J.J. Synopsis Methodica Stirpium Britannicarum, 3rd ed.; G. and J. Innys: London, UK, 1724; p. 482.
10. Martin, M. A Description of the Western Isles of Scotland, 4th ed.; Macleod, D.J., Ed.; Stirling: Eneas Mackay: Cornhill, UK, 1934.
11. Lightfoot, J. Flora Scotica; Benjamin White: London, UK, 1977, Volume 2.
12. Beith, M. Healing Threads: Traditional Medicines of the Highlands and Islands Edinburgh; Polygon: Edinburgh, UK, 1999.
13. Svabo, J.C. Indberetninger fra en Reise I Færøe 1781 og 1782; Selskabet til Udgivelse af Færøske Kildeskrifter og Studier: Copenhagen, Denmark, 1959, p. 497.
14. Allen, D.E.; Hatfield, G. Medicinal Plants in Folk Tradition: An Ethnobotany of Britain and Ireland; Timber Press: Cambridge, UK, 2004; p. 431.
15. Swanton, E.W. Economic and folklore notes. Trans. Br. Mycol. Soc. 1915, 5, 408-409.
16. Swanton, E.W. Sussex County Magazine; T.R. Beckett: Eastbourne, UK, 1932, Volume 6, p. 709.
17. Hatfield, G. Country Remedies: Traditional East Anglian Plant Remedies in the Twentieth Century; Boydell Press: Woodbridge, UK, 2005.
18. Müller, K. Pharmaceutically relevant metabolites from lichens. Appl. Microbiol. Biotechnol. 2001, 56, 9.
19. Purvis, W. Lichens; Natural History Museum, London/Smithsonian Institution: Washington D.C., USA, 2000; p. 112.
20. MacFarlane, A.M. Gaelic names of plants: Study of their uses and lore. Trans. Gaelic Soc. Inverness 1929, 32, 1-48.
21. Cameron, J. The Gaelic names of plants (Scottish, Irish and Mnax) Collected and Artanged in Scientific Order, with Notes on Their Etymology, Uses, Plant Superstitions, etc., among the Celts, with Copious Gaelic, English and Scientific Indices; John Mackay: Glasgow, Scotland, UK, 1900; p. 160.
22. Vickery, R. A Dictionary of Plant-Lore; Oxford University Press: Oxford, UK, 1995.
23. Moloney, M.F. Irish Ethno-botany and the Evolution of Medicine in Ireland; Dublin, M.H., Ed.; Gill and Son: Dublin, Ireland, 1919.
24. Borlase, W. The Natural History of Cornwall; E. & W. Books: Oxford, UK, 1758.
25. Ó hEithir, R. Folk Medical Beliefs and Practices in the Aran Islands. Master's thesis, National University of Ireland, Galway, Ireland, 1983.
26. Dewick, P.M. Medicinal Natural Products: A Biosynthentic Approach, 2nd ed.; John Wiley and Son: West Sussex, UK, 2002; p. 520.
27. Maplestone, R.A.; Stone, M.J.; Williams, D.H. The evolutionary role of secondary metabolites-A review. Gene 1992, 115, 151-157.
28. Colegate, S.M.; Molyneux, R.J. Bioactive Natural Products: Detection, Isolation and Structure Determination; CRC Press: Boca Raton, FL, USA, 2008; pp. 421-437.
29. Sarker, S.D.; Latif, Z.; Gray, A.I. Methods in Biotechnology: Natural Product Isolation; Satyajit D., Ed.; Human Press Inc: Totowa, NJ, USA, 2006; p. 528.
30. Der Marderosian, A.; Beutler, J.A. The Review of Natural Products, 2nd ed.; Facts and Comparisons; Seattle, WA, USA, 2002; pp. 13-43.
31. Aniszewski, T. Alkaloids-Secrets of Life. In Alkaloid Chemistry, Biological Significance, Applications and Ecological Role; Elsevier Science: Amsterdam, The Netherlands, 2007; p. 334.
32. Lorenzen, K.; Anke, T. Basidiomycetes as a source for new bioactive natural products. Curr. Org. Chem. 1996, 2, 329-364.
33. Mann, J. Murder, Magic, and Medicine; Oxford University Press: New York, NY, USA, 1994; pp. 164-170.
34. Abraham, E.P.; Chain, E.; Fletcher, C.M. Further observations on penicillin. Lancet 1941, 16, 177-189.
35. Alder, A.L. The History of Penicillin Production; American Institute of Chemical Engineers: New York, NY, USA, 1970.
36. Lax, E. The Mold in Dr. Florey's Coat: The Story of the Penicillian Miracle; John Macrae/Henry Hol: New York, NY, USA, 2004; p. 308.
37. Wainwright, M. Miracle Cure: The Story of Penicillin and the Golden Age of Antibiotics; Blackwell Scientific: Oxford, UK, 1990; p. 57.
38. Mann, J. The Elusive Magic Bullet: The Search for the Perfect Drug; Oxford University Press: New York, NY, USA, 1999.
39. Williams, J.D. β-lactamases and β-lactamase inhibitor. Int. J. Antimicrob. Agents 1999, 12 (Suppl. 1), S2-S7.
40. Buss, A.D.; Waigh, R.D. Antiparasitic drugs. In Burger's Medicinal Chemistry and Drug Discovery, 5th ed.; Wolff, M.E., Ed.; Wiley-Interscience: New York, NY, USA, 1995; Volume 1, pp. 1021-1028.
41. Fabbretti, A.; Gualerzi, C.O.; Brandi, L. How to cope with the quest for new antibiotics. FEBS Lett. 2011, 585, 1673-1681.
42. Zjawiony, J.K. Biologically active compounds from aphyllophorales (Polypore) fungi. J. Nat. Prod. 2004, 67, 300-310.
43. Stamets, P. Novel Antimicrobials from mushrooms. Herbal Gram 2002, 54, 28-33.
44. Gwinn, K.D.; Schardl, C.L.; Friburg, A. Southern regional information exchange group (SRIEG-37) on the tall fescue endophyte. J. Prod. Agric. 1992, 5, 189-190.
45. Tan, R.X.; Zou, W.X. Endophytes: A rich source of functional metabolites (1987 to 2000). Nat. Prod. Rep. 2001, 18, 448-459.
46. Petrini, O. Taxonomy of endophytic fungi of aerial plant tissues. In Microbiology of Phyllosphere; Fokkema, N.J., van den Heuvel, J., Eds.; Cambridge University Press: Cambridge, UK, 1986; pp, 175-187.
47. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461-477.
48. Martin, D.E.; Blum, R.; Wilton, J. Safety and pharmacokinetics of beririmat (PA-457) a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers. Antimicrob. Agents Chemother. 2007, 51, 3063-3066.
49. Kashiwada, Y.; Hashimoto, F.; Cosentino, L.M. Betulinic acid and dihydrobetulinic acid derivatives as potent HIV agents. J. Med. Chem. 1996, 39, 1016-1017.
50. Yogeeswari, P.; Sriram, D. Betulinic acid and its derivatives: A review on their biological properties. Curr. Med. Chem. 2005, 12, 763-771.
51. Heider, D.; Verheyen, J.; Hoffman, D. Predicting Bevirimat resistance of HIV-1 from genotype. BMC Bioinformatics 2010, 11, 1-9.
52. Min, B.-S.; Nakamura, N.; Miyashiro, H.; Bae, K.-W.; Hattori, M. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem. Pharm. Bull. 1998, 46, 1607-1612.
53. Lee, J.C.; Strobel, G.A.; Lobkovsky, E.; Clardy, J.C. Torreyanic acid: A selectively cytotoxic quinone dimer from the endophytic fungus Pestalotiopsis microspora. J. Org. Chem. 1996, 61, 3232-3233.
54. Li, C.; Johnson, R.P.; Porco, J.A. Total synthesis of the quinine epoxide dimer (+)-torreyanic acid: application of a biomimetic oxidation/electrocyclization/Diels-Alder dimerization cascade. J. Am. Chem. Soc. 2003, 125, 5059-5106.
55. McRae, J.; Yang, Q.; Crawford, R.; Palombo, W. Review of the methods used for isolating pharmaceutical lead compounds from traditional medicinal plants. Environmentalist 2007, 27, 165-174.
56. Fellows, L.; Scofield, A. Chemical diversity in plants. In Intellectual Property Rights and Biodiversity Conservation-An Interdisciplinary Analysis of the Values of Medicinal Plants; University Press: Cambridge, UK, 1995.
57. Farnsworth, N.R.; Akerele, R.O.; Bingel, A.S.; Soejarto, D.D.; Guo, Z. Medicinal Plants in Therapy. Bull. WHO 1985, 63, 965-981.
58. Fabricant, D.S.; Farnsworth, N.R. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 2001, 109, 69-75.
59. Cragg, G.M. Paclitaxel (Taxol): A success story with valuable lessons for natural product drug discovery and development. Med. Res. Rev. 1998, 18, 315-331.
60. Cseke, L.J.; Kirakosyan, A.; Kaufmann, P.B.; Warber, S.L.; Duke, J.A.; Brielmann, H.L. Natural Products from Plants, 2nd ed.; CRC, Taylor and Francis: Boca Raton, FL, USA, 2006; p. 640.
61. Nicolaou, K.C.; Yang, Z.; Liu, J.J.; Ueno, H.; Nantermet, P.G.; Guy, R.K.; Claiborne, C.F.; Renaud, J.; Couladouros, E.A.; Paulvannan, K.; Sorensen, E.J. Total synthesis of taxol. Nature 1994, 367, 630-634.
62. Kedei, N.; Lundberg, D.J.; Toth, A.; Welburn, P.; Garfield, S.H.; Blumberg, P.M. Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res. 2004, 64, 3243-3255.
63. Ogbourne, S.M.; Suhrbier, A.; Jones, B. Antitumour activity of ingenol 3-angelate: Plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Res. 2004, 64, 2833-2839.
64. Kiviharju, T.M.; Lecane, P.S.; Sellers, R.G.; Peehl, D.M. Antiproliferative and proapoptic of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin. Cancer. Res. 2002, 8, 2666-2674.
65. Fidler, J.M.; Li, K.; Chung, C. PG490-88, a derivative of triptolide, casues tumor regression and sensitizes tumors to chemotherapy. Mol. Cancer. Ther. 2003, 2, 855-862.
66. Newman, D.J.; Cragg, G.M. In Drug Discovery, Therapeutics, and Preventive Medicine; Zhang, L., Fleming, A., Demain, A.L., Eds.; Humana Press: Totowa, NJ, USA, 2005; p. 74.
67. Holwell, S.E.; Cooper, P.A.; Grosios, J.W.; Lippert, J.W., III; Pettit, G.R.; Snyder, S.D.; Bibby, M.C. Combretastatin A-1 phosphate, a novel tubulin-binding agent with in-vivo anti-vascular effects in experimental tumors. Anticancer Res. 2002, 22, 707-712.
68. Kashman, Y.; Gustafson, K.R.; Fuller, R.W.; Cardellin, J.H., II; McMahon, J.B.; Currens, M.J.; Buckheist, R.W.; Hughes, S.H.; Cragg, G.M.; Boyd, M.R. The Calanolides, a novel HIVinhibitory class of coumarin derivatives from the tropical rainforest tree, calophyllum lanigerum. J. Med. Chem. 1992, 35, 2735-2743.
69. Gustafson, K.R.; Cardellin, J.H., II; McMahon, J.B.; Gulakowski, R.J.; Ishitoya, J.; Szallasi, Z.; Lewin, N.E.; Blumberg, P.M.; Weislow, O.S.; Beutler, J.A.; et al. A nonpromoting phorbol from the Samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1. J. Med. Chem. 1992, 35, 1978-1986.
70. Cox, P.A. Saving the Ethnopharmacological Heritage of Samoa. Pharm. Biol. 2001, 39, 33-40.
71. Davidson, R.N.; den Boer, M.; Ritmeijer, K. Paromomycin. Trans. R. Soc. Trop. Med. Hyg. 2009, 103, 653-660.
72. Carroll, A.R.; Arumugan, G.; Quinn, R.J.; Redburn, J.; Guymer, G.; Grimshaw, P. Grandisine A and B, novel indolizidine alkaloids with-opioid receptor binding affinity from the leaves of the human australian rainforest tree Elaeocarpus grandis. J. Org. Chem. 2005, 70, 1889-1892.
73. Howes, M.-J.R.; Perry, N.S.L.; Houghton, P.J. Plants with traditional uses and activitities, relevant to the management of Alzheimer's disease and other cognitive disorders. Phytother. Res. 2003, 17, 1-18.
74. Heinrich, M.; Teoh, H.L. Galanthamine from snowdrop-the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. J. Ethnopharmacol. 2004, 92, 147-162.
75. Deleu, D.; Hanssens, Y.; Northway, M.G. Subcutaneous apomorphine: An evidence-based review of its use in Parkinson's disease. Drugs Aging 2004, 21, 687-709.
76. Marris, E. Marine natural products: Drugs from the deep. Nature 2006, 443, 904-905.
77. Haefner, B. Drugs from the deep: Marine natural products as drug candidates. Drug Discov. Today 2003, 8, 536-544.
78. Alejandro, M.; Glaser, K.B.; Cuevas, C.; Jacobs, R.S.; Kem, W.; Little, R.D.; McIntosh, J.M.; Newman, D.J.; Potts, B.C.; Shuster, D.E. The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharm. Sci. 2010, 31, 255-265.
79. Rinehart, K.L.; Lithgow-Bertelloni, A.M. Novel antiviral and cytotoxic agent, dehydrodidemnin B. PCT Int. Pat. Appl. 1991, 15, 248086q.
80. Urdiales, J.L.; Morata, P.; De Castro, I.N.; Sanchez-Jimenez, F. Anti-proliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates. Cancer Lett. 1996, 102, 31-37.
81. Henríquez, R.; Faircloth, G.; Cuevas, C. In Ecteinascidin 743 (ET-743, Yondelis), aplidin, and kahalalide F. In Anticancer Agents from Natural Products; Cragg, G.M., Kingston, D.G.I., Newman, D.J., Eds.; Taylor and Francis: Boca Raton, FL, USA, 2005; p. 215.
82. Rinehart, K.L.; Holt, T.G.; Fregeau, N.L.; Stroh, J.G.; Keifer, P.A.; Sun, F.; Li, L.H.; Martin, D.G. Ecteinascidins 729, 743, 745, 759A, 759B, and 770: Potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata. J. Org. Chem. 1990, 55, 4512-4515.
83. Wright, A.E.; Forleo, D.A.; Gunawardana, G.P.; Gunasekera, S.P.; Koehn, F.E.; McConnell, O.J. Antitumor tetrahydroisoquinoline alkaloids from the colonial ascidian Ecteinascidia turbinata. J. Org. Chem. 1990, 55, 4508-4512.
84. Manzanares, I.; Cuevas, C.; Garcia-Nieto, R.; Marco, E.; Gago, F. Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anticancer agents. Curr. Med. Chem. Anticancer Agents 2001, 1, 257.
85. Cuevas, C.; Francesch, A. Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem. Nat. Prod. Rep. 2009, 26, 322-337.
86. Alvarez-Miranda, M.; Rodriguez-Gonzalez, A.; Ptero, G.; Lacal, J.C. Characterization of the mechanism of action of ES-285, a novel antitumor drug from Mactomeris polynyma. Clin. Cancer Res. 2003, 9, Abstract C17.
87. Cuadros, R.; Montejo de Garcini, E.; Wandosell, F.; Faircloth, G.; Fernandez-Sousa, J.M.; Avila, J. The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers. Cancer Lett. 2000, 152, 23.
88. Salcedo, M.; Cuevas, C.; Otero, G.; Sanchez-Puelles, J.M.; Fernandez-Sousa, J.M.; Avila, J.; Wandosell, F. The marine antitmor compound ES 285 activates EGD receptors. Clin. Cancer Res. 2003, 9, Abstract C24.
89. Salcedo, M.; Cuevas, C.; Sanchez-Puelles, J.M.; Otero, G.; Sousa, J.M.F.; Avila, J.; Wandosell, F. ES-285, a novel antitumoral compound, interacts with EDG receptors. Proceedings of American Association for Cancer Research 94th Meeting, Washington, 11-14 July, 2003, Abstract 3649.
90. Trimurtulu, G.; Ohtani, I.; Patterson, G.M.L.; Moore, R.E.; Corbett, T.H.; Valeriote, F.A.; Demchik, L. Total structures of cryptophycins, potent antitumor depsipeptides from the bluegreen alga Nostoc sp. strain GSV 224. J. Am. Chem. Soc. 1994, 116, 4729-4737.
91. Faulkner, D.J. Marine natural products. J. Nat. Prod. Rep. 2002, 19, 1-48.
92. Bhakuni, D.S.; Rawat, D.S. Bioactive Marine Natural Products, 1st ed.; Springer-Verlag: New Delhi, India, 2005; p. 404.
93. Baslow, M.N. Marine Pharmacology; A Study of Toxins and Other Biologically Active Substances of Marine Origin; Williams & Wilkins Co: Baltimore, MD, USA, 1969; p. 286.
94. Yotsu-Yamashita, M.; Haddock, R.L.; Yasumoto, T. Polycavernoside A: a novel glycosidic macrolide from the red alga Polycavernosa tsudai (Gracilaria edulis). J. Am. Chem. Soc. 1993, 115, 1147-1148.
95. White, J.D.; Blakemore, P.R.; Browder, C.C.; Hong, J.; Lincoln, C.M.; Nagornyy, P.A.; Robarge, L.A.; Wardrop, D.J. Total synthesis of the marine toxin polycavernoside A via selective macrolactonization of a trihydroxy carboxylic acid. J. Am. Chem. Soc. 2001, 123, 8593-8595.
96. Paquette, L.A.; Barriault, L.; Pissarnitski, D.; Johnston, J.N. Stereocontrolled elaboration of natural (-)-Polycavernoside A, a powerfully toxic metabolite of the red alga Polycavernosa tsudai. J. Am. Chem. Soc. 2000, 122, 619-631.
97. Ishitsuka, M.O.; Kusumi, T.K.H. Antitumor xenicane and norxenicane lactones from the brown alga Dictyota dichotoma. J. Org. Chem. 1988, 53, 5010-5013.
98. Faulkner, D.J. Marine natural products. Nat. Prod. Rep. 1988, 20, 269-309.
99. Tringali, C.; Oriente, G.; Piattelli, M.; Geraci, C.; Nicolosi, G.; Breitmaier, E. Crenuladial, an antimicrobial diterpenoid from the brown alga Dilophus ligulatus. Can. J. Chem. 1988, 66, 2799-2802.
100. San-Martin, A.; Darias, J.; Soto, H.; Contreras, C.; Herrera, J.S.; Rovirosa, J. A new C15 acetogenin from the marine alga Laurencia claviformis. Nat. Prod. Lett. 1997, 10, 303-311.
101. Kimura, J.; Kamada, N.; Yoshikazu, T. Fifteen chamigrane derivatives from the red alga Laurencia nidifica. Bull. Chem. Soc. Jpn. 1999, 72, 289-88292.
102. Elsworth, J.M. A new chamigrane from Laurencia glomerata. J. Nat. Prod. 1989, 52, 893-895.
103. Dias, D.A.; White, J.M.; Urban, S. Laurencia filiformis: Phytochemical profiling by conventional and HPLC-NMR approaches. Nat. Prod. Commun. 2009, 4, 157-172.
104. Dias, D.A.; Urban, S. Phytochemical studies of the southern Australian marine alga, Laurencia elata. Phytochemistry 2011, 72, 2081-2089.
105. Duke, S.O.; Menn, J.J.; Plimmer, J.R. Pest Control with Enhanced Environmental Safety; ACS Symposium Series No. 514; Duke, S.O., Menn, J.J., Plimmer, J.R., Eds.; American Chemical Society: Washington, DC, USA, 1993.
106. Georghiou, G.P. Overview of insecticide resistance. In Managing Resistance to Agrochemicals: From Fundamental Research to Practical Strategies; Green, M.B., Le Baron, H.M., Moberg, W.K., Eds.; ACS Symp. Ser. 421. Am. Chem. Soc: Washington, DC, USA, 1990; pp. 18-41.
107. El Sayed, K.A.; Dunbar, D.C.; Perry, T.L.; Wilkins, S.P.; Hamann, M.T.; Greenplate, J.T.; Wideman, M.A. Marine natural products as prototype insecticidal agents. J. Agric. Food Chem. 1997, 45, 2735-2739.
108. San-Martin, A.; Negrete, R.; Rovirosa, J. Insecticide and acaricide activities of polyhalogenated monoterpenes from Chilean Plocamium cartilagineum. Phytochemistry 1991, 30, 2165-2169.
109. Fukuzawa, A.; Masamune, T. Laurepinnacin and isolaurepinnacin, new acetylenic cyclic ethers from the marine red alga Laurencia pinnata Yamada. Tetrahedron Lett. 1981, 22, 4081-4084.
110. Watanabe, K.; Umeda, K.; Miyakado, M. Isolation and identification of three insecticidal principles from the red alga Laurencia nipponica Yamada. Agric. Biol. Chem. 1989, 53, 2513-2515.
111. McConnell, O.; Longley, R.E.; Koehn, F.E. The Discovery of Natural Products with Therapeutic Potential; Gullo, V.P., Ed.; Butterworth-Heinemann: Boston, MA, USA, 1994; pp. 109-174.
112. Newman, D.J.; Cragg, G.M.; Snader, K.M. The influence of natural products on drug discovery. Nat. Prod. Rep. 2000, 17, 215-234.
113. Chin, Y.-W.; Balunas, M.J.; Chai, H.B.; Kinghorn, A.D. Drug discovery from natural sources. AAPS J. 2006, 8, 239-253.
114. Uemura, D.; Takahashi, K.; Yamamoto, T.; Katayama, C.; Tanaka, J.; Okumura, Y.; Hirata, Y. Norhalichondrin A: An antitumor polyether macrolide from a marine sponge. J. Am. Chem. Soc. 1985, 107, 4796-4798.
115. Pettit, G.R.; Herald, C.L.; Boyd, M.R.; Leet, J.E.; Dufresne, C.; Doubek, D.L.; Schmidt, J.M.; Cerny, R.L.; Hooper, J.N.A.; Rutzler, K.C. Antineoplastic agents. 219. Isolation and structure of the cell growth inhibitory constituents from the western Pacific marine sponge Axinella sp. J. Med. Chem. 1991, 34, 3339-3340.
116. Pettit, G.R.; Srirangam, J.K.; Herald, D.L.; Erickson, K.L.; Doubek, D.L.; Schmidt, J.M.; Tackett, L.P.; Bakus, G.J. Antineoplastic agents. 251. Isolation and structure of stylostatin 1 from the Papua New Guinea marine sponge Stylotella sp. J. Org. Chem. 1993, 58, 3222.
117. Litaudon, M.; Hart, J.B.; Blunt, J.W.; Lake, R.J.; Munro, M.H.G. Isohomohalichondrin B, a new antitumour polyether macrolide from the New Zealand deep-water sponge, Lyssodendoryx sp. Tetrahedron Lett. 1994, 35, 9435.
118. Aicher, T.D.; Buszek, K.R.; Fang, F.G.; Forsyth, C.J.; Jung, S.H.; Kishi, Y.; Matelich, M.C.; Scola, P.M.; Spero, D.M.; Yoon, S.K. Total synthesis of halichondrin B and norhalichondrin B. J. Am. Chem. Soc. 1992, 114, 3162-3164.
119. Baker, D.D.; Chu, M.; Oza, U.; Rajgarhia, V. The value of natural products to future pharmaceutical discovery. Nat. Prod. Rep. 2007, 24, 1225-1244.
120. Ojima, I. Modern natural products chemistry and drug discovery. J. Med. Chem. 2008, 51, 2587-2588.
121. Nussbaum, F.V.; Brands, M.; Hinzen, B.; Weigand, S.; Habich, D. Antibacterial natural products in medicinal chemistry-exodus or revival? Angew. Chem. Int. Ed. 2006, 45, 5072-5129.
122. Luzhetskyy, A.; Pelzer, S.; Bechthold, A. The future of natural products as a source of new antibiotics. Curr. Opin. Investig. Drugs 2007, 8, 608-613.
123. Newman, D.J. Natural products as leads to potential drugs: An old process or the new hope for drug discovery? J. Med. Chem. 2008, 51, 2589-2599.
124. Ramakrishna, N.V.S.; Nadkarni, S.R.; Bhat, R.G.; Naker, S.D.; Kumar, E.K.S.V.; Lal, B. Screening of natural product extracts for antibacterial activity: Early identification and elimination of known compounds by dereplication. Ind. J. Chem. 1999, 38B, 1384-1387.
125. Sashidhara, K.V.; Rosaiah, J.N. Various dereplication strategies using LC-MS for rapid natural product lead identification and drug discovery. Nat. Prod. Commun. 2007, 2, 193-202.
126. Cordell, G.A.; Shin, Y.G. Finding the needle in the haystack. The dereplication of natural product extracts. Pure Appl. Chem. 1999, 71, 1089-1094.
127. Brkljaca, R.; Urban, S. Recent advances in HPLC-NMR and applications for natural product profiling and identification. J. Liq. Chroma. Rel. Technol. 2011, 34, 1063-1076.
128. Blunt, J.W.; Munro, M.H.G. Dictionary of Marine Natural Products. Available online: http://dmnp.chemnetbase.com/ (accessed on 21 July 2009).
129. Buckingham, J. The Dictionary of Natural Products. Available online: http://dmnp.chemnetbase.com/ (accessed on 22 August 2011).
130. MarinLit. Available online: http://www.chem.canterbury.ac.nz/marinlit/marinlit.shtml (accessed on 23 June 2011).
131. Blunt, J.W.; Munro, M.H.G.; Laatsch, H. AntiMarin Database. Available online: http://www.chem.canterbury.ac.nz/marinlit/marinlit.shtml (accessed on 10 April 2012).
132. Lang, G.; Mayhudin, N.A.; Mitova, M.I.; Sun, L.; van der Sar, S.; Blunt, J.W.; Cole, A.L.J.; Ellis, G.; Laatsch, H.; Munro, M.H.G. Evolving trends in the dereplication of natural product extracts: New methodology for rapid, small-scale investigation of natural product extracts. J. Nat. Prod. 2008, 19, 1595-1599.
133. SciFinder Scholar. Available from: http://www.cas.org/SCIFINDER/SCHOLAR/ (accessed on 2 July 2011).
134. SCOPUS. Available online:http://www.scopus.com/home.url (accessed on 25 August 2011).
135. Napralert. http://www.napralert.org/ (accessed on 3 May 2011).
136. Urban, S.; Separovic, F. Developments in hyphenated spectroscopic methods in natural product profiling. Front. Drug Des. Discov. 2005, 1, 113-166.
137. Wolfender, J.-L.; Ndjoko, K.; Hostettman, K. Liquid chromatography with ultraviolet absorbance-mass spectrometric detection and with nuclear magnetic resonance spectroscopy: A powerful combination for the on-line structural investigation of plant metabolites. J. Chromatogr. A 2003, 1000, 437-455.
138. Wolfender, J.-L.; Queiroz, E.F.; Hostettman, K. The importance of hyphenated techniques in the discovery of new lead compounds from nature. Expert Opin. Drug Dis. 2006, 1, 237-260.
139. Schroeder, F.C.; Gronquist, M. Extending the scope of NMR spectroscopy with microcoil probes. Angew. Chem. Int. Ed. 2006, 45, 7122-7131.
140. Lewis, R.J.; Bernstein, M.A.; Duncan, S.J.; Sleigh, C.J. A comparison of capillary-scale LC-NMR with alternative techniques: Spectroscopic and practical considerations. Magn. Reson. Chem. 2005, 43, 783-789.
141. Dias, D.; Urban, S. Phytochemical analysis of the southern australian marine alga, Plocamium mertensii using HPLC-NMR. Phytochem. Anal. 2008, 19, 453-470.
142. Dias, D.A.; Urban, S. Application of HPLC-NMR for the rapid chemical profiling of a Southern Australian Sponge, Dactylospongia sp. J. Sep. Sci. 2009, 32, 542-548.
143. Lin, Y.; Schiavo, S.; Orjala, J.; Vouros, P.; Kautz, R. Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites. Anal. Chem. 2008, 80, 8045-8054.
144. Sun Lin, J.; Mahyudin, N.A.; Chamyuang, S.; Blunt, J.W.; Cole, T.; Lang, G.; Mitova, M.I.; van der Sar, S.; Munro, M.H.G. Less is more: Dereplication and discovery using CapNMR techniques. Proceedings of Manapro XII: 12th International Symposium of Marine Natural Products, Queenstown, New Zealand, Feb 4th-9th, 2007.
145. Clarkson, C.; Stærk, D.; Hansen, S.H.; Smith, P.J.; Jaroszewski, J.W. Discovering new natural products directly from crude extracts by HPLC-SPE-NMR: Chinane diterpenes Harpagophytum procumbens. J. Nat. Prod. 2006, 69, 527-530.
146. Cogne, A.-L.; Queiroz, E.F.; Marston, A.; Wolfender, J.L.; Mavi, S.; Hostettmann, K. On-line identification of unstable iridoids from Jamesbrittenia fodina by HPLC-MS and HPLC-NMR. Phytochem. Anal. 2005, 16, 429-439.
147. Zschocke, S.; Klaiber, I.; Bauer, R.; Vogler, B. HPLC-coupled spectroscopic techniques (UV, MS, NMR) for the structure elucidation of phthalides in Ligusticum chuanxiong. Mol. Divers. 2005, 9, 33-39.
148. Roessner, U.; Beckles, D.M. Metabolite measurements. In Plant Metabolic Networks; Junker, B., Schwender, J., Eds.; Springer: Heidelberg, Germany, 2009.
149. Roessner, U.; Nahid, A.; Hunter, A.; Bellgard, M. Metabolomics-The combination of analytical chemistry, biology and informatics. In Comprehensive Biotechnology, 2nd ed.; Moo-Young, M., Ed.; Springer: Heidelberg, Germany, 2011; Volume 1, pp. 447-459.
150. Beckles, D.M.; Roessner, U. Plant Metabolomics-Applications and opportunities for agricultural biotechnology. In Plant Biotechnology and Agriculture: Prospects for the 21st Century; Altmann, A., Hasegawa, P.M., Eds.; Elsevier/Academic Press: Boston, MA, USA, 2011.
151. Rochfort, S. Metabolomics reviewed: A new "Omics" platform technology for systems biology and implications for natural products research. J. Nat. Prod. 2005, 68, 1813-1820.
152. Cortina, N.S.; Krug, D.; Plaza, A.; Revermann, O.; Muller, R. Myxoprincomide: A natural product from Myxococcus xanthus discovered by comprehensive analysis of the secondary metabolome. Angew. Chem. Int. Ed. 2012, 51, 811-816.
153. Guoxiang, X.; Robert, P.; Mingming, S.; Zhaohui, X.; Aihua, Z.; Mingfeng, Q.; Xiangbao, L.; Zhong, L.; Wei, J. Ultra-performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research. J. Sep. Sci. 2008, 31, 1015-1026.
154. Politi, M.; Peschel, W.; Wilson, N.; Zloh, M.; Prieto, J.M.; Heinrich, M. Cannabis water extracts and tinctures analysed by NMR spectroscopy; different strategies to reduce the content of D9-THC. Phytochemistry 2008, 69, 562-570.
155. Verpoorte, R.; Choi, Y.H.; Kim, H.K. Ethnopharmacology and systems biology: A perfect holistic match. J. Ethnopharmacol. 2005, 100, 53-56.
156. Wang, M.; Lamers, R.J.A.N.; Korthout, H.A.; Van Nesselrooij, J.H.J.; Witkamp, R.F.; Van der Heijden, R. Metabolomics in the context of systems biology: Bridging traditional Chinese medicine and molecular pharmacology. Phytother. Res. 2005, 3, 173-182.
157. Cardoso-Taketa, A.T.; Pereda-Miranda, R.; Choi, Y.H.; Verpoorte, R.; Villarreal, M.L. Metabolic profiling of the Mexican anxiolytic and sedative plant Galphimia glauca using nuclear magnetic resonance spectroscopy and multivariate data analysis. Planta Med. 2008, 74, 1295-1301.
158. Biao-Yi, Z.; Yan Yu, Y.; Zeng-Liang, Y. Investigation of antimicrobial model of Hemsleya pengxianensis W.J. Chang and its main active component by metabolomics technique. J. Ethnopharmacol. 2008, 116, 89-95.
159. Kim, H.K.; Choi, Y.H.; Verpoorte, R. NMR-based metabolomic analysis of plants. Nat. Protoc. 2010, 5, 536-549.
160. Deyrupa, S.T.; Eckman, L.E.; McCarthy, P.H.; Smedley, S.R.; Meinwald, J.; Schroeder, F.C. 2D NMR-spectroscopic screening reveals polyketides in ladybugs. Proc. Natl. Acad. Soc. USA 2011, 108, 9753-9758.